アステラス製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/03/15 | 1,724.5 | 1,748.5 | 1,724.5 | 1,738 | +13.5 | +0.8% | 6,583,600 |
2019/03/14 | 1,740 | 1,746.5 | 1,723 | 1,724.5 | +5.5 | +0.3% | 5,264,300 |
2019/03/13 | 1,727.5 | 1,730 | 1,700.5 | 1,719 | -13 | -0.8% | 5,090,100 |
2019/03/12 | 1,719.5 | 1,738.5 | 1,710.5 | 1,732 | +27.5 | +1.6% | 4,991,400 |
2019/03/11 | 1,696 | 1,713.5 | 1,692 | 1,704.5 | +6.5 | +0.4% | 4,770,500 |
2019/03/08 | 1,718 | 1,727 | 1,695 | 1,698 | -26 | -1.5% | 10,236,200 |
2019/03/07 | 1,709 | 1,740 | 1,709 | 1,724 | -10 | -0.6% | 6,105,600 |
2019/03/06 | 1,768 | 1,768.5 | 1,726.5 | 1,734 | -34.5 | -2% | 6,443,700 |
2019/03/05 | 1,749 | 1,769 | 1,743.5 | 1,768.5 | +6.5 | +0.4% | 5,199,100 |
2019/03/04 | 1,767.5 | 1,769.5 | 1,750 | 1,762 | +19.5 | +1.1% | 4,907,300 |
2019/03/01 | 1,726.5 | 1,748.5 | 1,724.5 | 1,742.5 | +24 | +1.4% | 5,531,900 |
2019/02/28 | 1,731 | 1,740 | 1,716 | 1,718.5 | -16 | -0.9% | 8,654,800 |
2019/02/27 | 1,718.5 | 1,745.5 | 1,718 | 1,734.5 | +27 | +1.6% | 7,886,300 |
2019/02/26 | 1,687.5 | 1,710.5 | 1,687 | 1,707.5 | +21 | +1.2% | 5,932,200 |
2019/02/25 | 1,703 | 1,707 | 1,682.5 | 1,686.5 | -16.5 | -1% | 6,048,100 |
2019/02/22 | 1,688 | 1,709 | 1,687.5 | 1,703 | +14.5 | +0.9% | 5,289,700 |
2019/02/21 | 1,691.5 | 1,709.5 | 1,685.5 | 1,688.5 | -18.5 | -1.1% | 7,025,700 |
2019/02/20 | 1,699.5 | 1,711.5 | 1,696.5 | 1,707 | +18 | +1.1% | 6,720,600 |
2019/02/19 | 1,688.5 | 1,702 | 1,676 | 1,689 | -0.5 | ±0% | 5,544,800 |
2019/02/18 | 1,706.5 | 1,715.5 | 1,681 | 1,689.5 | +11.5 | +0.7% | 5,157,800 |
2019/02/15 | 1,653.5 | 1,684.5 | 1,647.5 | 1,678 | +2 | +0.1% | 6,494,800 |
2019/02/14 | 1,658.5 | 1,688 | 1,654 | 1,676 | +13 | +0.8% | 5,438,900 |
2019/02/13 | 1,672 | 1,684.5 | 1,658.5 | 1,663 | -9 | -0.5% | 7,313,000 |
2019/02/12 | 1,640 | 1,682.5 | 1,636 | 1,672 | +54 | +3.3% | 7,251,500 |
2019/02/08 | 1,605 | 1,644 | 1,602 | 1,618 | -43 | -2.6% | 10,332,400 |
2019/02/07 | 1,657 | 1,671.5 | 1,632.5 | 1,661 | -13.5 | -0.8% | 6,999,100 |
2019/02/06 | 1,668 | 1,705 | 1,665 | 1,674.5 | +6.5 | +0.4% | 8,608,500 |
2019/02/05 | 1,740 | 1,741.5 | 1,668 | 1,668 | -82 | -4.7% | 10,997,000 |
2019/02/04 | 1,684 | 1,750.5 | 1,680.5 | 1,750 | +57.5 | +3.4% | 8,601,600 |
2019/02/01 | 1,610 | 1,692.5 | 1,609 | 1,692.5 | +83 | +5.2% | 10,051,700 |
2019/01/31 | 1,554 | 1,626 | 1,534 | 1,609.5 | +61.5 | +4% | 10,470,700 |
2019/01/30 | 1,539 | 1,556.5 | 1,522.5 | 1,548 | +6.5 | +0.4% | 7,193,000 |
2019/01/29 | 1,526.5 | 1,544.5 | 1,506.5 | 1,541.5 | +12.5 | +0.8% | 5,432,300 |
2019/01/28 | 1,533 | 1,539 | 1,521.5 | 1,529 | -4 | -0.3% | 3,584,800 |
2019/01/25 | 1,549 | 1,569 | 1,528 | 1,533 | -36 | -2.3% | 6,608,100 |
2019/01/24 | 1,528.5 | 1,571.5 | 1,526.5 | 1,569 | +18 | +1.2% | 7,430,200 |
2019/01/23 | 1,547.5 | 1,554 | 1,523.5 | 1,551 | -7.5 | -0.5% | 4,918,300 |
2019/01/22 | 1,561 | 1,564 | 1,543.5 | 1,558.5 | ±0 | ±0% | 4,561,800 |
2019/01/21 | 1,582.5 | 1,583 | 1,554 | 1,558.5 | -3.5 | -0.2% | 3,408,200 |
2019/01/18 | 1,554 | 1,571 | 1,552.5 | 1,562 | +24 | +1.6% | 4,736,700 |
2019/01/17 | 1,528.5 | 1,546 | 1,516 | 1,538 | +1.5 | +0.1% | 4,030,400 |
2019/01/16 | 1,554 | 1,555 | 1,517 | 1,536.5 | -6.5 | -0.4% | 5,615,200 |
2019/01/15 | 1,510 | 1,549.5 | 1,504 | 1,543 | +23 | +1.5% | 7,590,000 |
2019/01/11 | 1,522.5 | 1,524 | 1,495.5 | 1,520 | +16.5 | +1.1% | 7,555,100 |
2019/01/10 | 1,509.5 | 1,513.5 | 1,490 | 1,503.5 | -20 | -1.3% | 5,621,500 |
2019/01/09 | 1,510.5 | 1,554 | 1,510 | 1,523.5 | +40.5 | +2.7% | 8,301,800 |
2019/01/08 | 1,472 | 1,486.5 | 1,451.5 | 1,483 | +27.5 | +1.9% | 7,945,500 |
2019/01/07 | 1,455.5 | 1,463.5 | 1,435 | 1,455.5 | +69.5 | +5% | 7,416,300 |
2019/01/04 | 1,381 | 1,393 | 1,356 | 1,386 | -15.5 | -1.1% | 9,437,100 |
2018/12/28 | 1,430 | 1,433.5 | 1,400 | 1,401.5 | -40.5 | -2.8% | 5,231,400 |
1501~
1550
件表示中 / 3697件
類似銘柄と比較する
現在ご覧いただいている「アステラス薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アステラス薬 | 137,200円 | +0.9% | +380.2% | 5.69% | 18.90倍 | 1.62倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
武 田 | 411,300円 | -1.1% | +75.3% | 4.86% | 28.18倍 | 0.93倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
大塚HD | 684,500円 | +2.2% | +10.2% | 1.75% | 13.15倍 | 1.32倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
塩野義 | 223,100円 | +20.9% | +10.6% | 2.96% | 10.55倍 | 1.39倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 399,900円 | +1.7% | -2.9% | 4.00% | 26.24倍 | 1.38倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム